Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2007. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 466908014 | Ferrocontin Continus 562.5mg m/r tablet | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| 719555015 | Ferrocontin Continus 562.5mg m/r tablet (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1191467011 | Ferrocontin Continus 562.5mg m/r tablet (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ferrocontin Continus 562.5mg m/r tablet | Is a | Ferrous glycine sulfate 562.5mg m/r tablet | false | Inferred relationship | Existential restriction modifier | ||
| Ferrocontin Continus 562.5mg m/r tablet | Has active ingredient | Trace element supplementation | false | Inferred relationship | Existential restriction modifier | ||
| Ferrocontin Continus 562.5mg m/r tablet | Has active ingredient | Iron | false | Inferred relationship | Existential restriction modifier | ||
| Ferrocontin Continus 562.5mg m/r tablet | Has active ingredient | Ferrous glycine sulfate | false | Inferred relationship | Existential restriction modifier | ||
| Ferrocontin Continus 562.5mg m/r tablet | Is a | Ferrous glycine sulfate 562.5mg m/r tablet | false | Inferred relationship | Existential restriction modifier | ||
| Ferrocontin Continus 562.5mg m/r tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR